Genetic Polymorphisms of Vitamin D Receptor Gene Are Associated with Cervical Cancer Risk in Northeastern Thailand

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2020 Oct 28

PMID 33112551

Citations 5

Authors

Sophida Phuthong

Wannapa Settheetham-Ishida

Sitakan Natphopsuk

Takafumi Ishida

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to explore whether VDR polymorphisms (Fok1, Apa1 and Taq1) are associated to the cervical cancer in Thai population.

Materials And Methods: Subjects of 204 cervical cancer patient and 204 age-matched healthy control were enrolled in the case-control study. VDR polymorphisms were detected by using real-time PCR. Haplotype analysis of three loci was applied to the obtained genotypes.

Results: Significantly increased risk for cervical cancer was observed in carriers of TT genotype (p = 0.0388) and T allele (p = 0.0357) of Fok1 and TC genotype (p = 0.0001), CC genotype (p = 0.0160) and the C allele of Taq1 (p = 0.0001). Haplotype analyses revealed a significant correlation between C-T-C, T-G-C and T-T-C haplotypes and elevated risk for cervical cancer (OR = 2.06; 95%CI = 1.06-4.00; p = 0.0313, OR = 2.15; 95%CI = 1.22-3.80; p = 0.0078 and OR = 2.81; 95%CI = 1.53-5.16; p = 0.0006, respectively). Furthermore, haplotype carrying C allele of Taq1 (C-G-C + C-T-C + T-G-C + T-T-C) significantly increased cervical cancer risk with OR of 1.92 (95%CI = 1.32-2.79, p = 0.0006).

Conclusion: Our finding revealed an association between VDR polymorphisms and cervical cancer risk. Taq1 C allele might be a molecular marker for cervical cancer development.<br />.

Citing Articles

Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis.

Farhangnia P, Noormohammadi M, Delbandi A Reprod Health. 2024; 21(1):61.

PMID: 38698459 PMC: 11064344. DOI: 10.1186/s12978-024-01797-y.

Cervical cancer in Thailand: 2023 update.

Wongpratate M, Bumrungthai S Obstet Gynecol Sci. 2024; 67(3):261-269.

PMID: 38528826 PMC: 11099091. DOI: 10.5468/ogs.23277.

Vitamin D and Its Receptors in Cervical Cancer.

Dong H, Chen S, Liang X, Cai Q, Zhang X, Xie J J Cancer. 2024; 15(4):926-938.

PMID: 38230221 PMC: 10788714. DOI: 10.7150/jca.87499.

The Preventive Role of the Vitamin D Endocrine System in Cervical Cancer.

Avila E, Noriega-Mejia B, Gonzalez-Macias J, Cortes-Hernandez U, Garcia-Quiroz J, Garcia-Becerra R Int J Mol Sci. 2023; 24(10).

PMID: 37240017 PMC: 10218637. DOI: 10.3390/ijms24108665.

Vitamin D Receptor Gene Polymorphisms and the Risk of CIN2+ in Shanxi Population.

Li D, Liu Y, Kong D, Papukashvili D, Rcheulishvili N, Zhao H Biomed Res Int. 2022; 2022:6875996.

PMID: 36440356 PMC: 9683960. DOI: 10.1155/2022/6875996.

References

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

Reichrath J, Rafi L, Muller S, Mink D, Reitnauer K, Tilgen W . Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor in cervical carcinoma. Histochem J. 1998; 30(8):561-7. DOI: 10.1023/a:1003283117492. View

Vahedpoor Z, Jamilian M, Bahmani F, Aghadavod E, Karamali M, Kashanian M . Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. Horm Cancer. 2017; 8(1):58-67. PMC: 10355858. DOI: 10.1007/s12672-016-0278-x. View

Whitfield G, Remus L, Jurutka P, Zitzer H, Oza A, Dang H . Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001; 177(1-2):145-59. DOI: 10.1016/s0303-7207(01)00406-3. View

Gapska P, Scott R, Serrano-Fernandez P, Huzarski T, Byrski T, Kladny J . Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat. 2008; 115(3):629-33. DOI: 10.1007/s10549-008-0107-1. View

Pike J, Meyer M . The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am. 2012; 38(1):13-27. PMC: 4448919. DOI: 10.1016/j.rdc.2012.03.004. View

Samuel S, Sitrin M . Vitamin D's role in cell proliferation and differentiation. Nutr Rev. 2008; 66(10 Suppl 2):S116-24. DOI: 10.1111/j.1753-4887.2008.00094.x. View

Deuster E, Jeschke U, Ye Y, Mahner S, Czogalla B . Vitamin D and VDR in Gynecological Cancers-A Systematic Review. Int J Mol Sci. 2017; 18(11). PMC: 5713297. DOI: 10.3390/ijms18112328. View

Wang K, Wu G, Li J, Song W . Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis. BMC Cancer. 2016; 16(1):674. PMC: 4995777. DOI: 10.1186/s12885-016-2722-2. View

10.

Bodiwala D, Luscombe C, French M, Liu S, Saxby M, Jones P . Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen. 2004; 43(2):121-7. DOI: 10.1002/em.20000. View

11.

Clendenen T, Arslan A, Koenig K, Enquist K, Wirgin I, Agren A . Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett. 2007; 260(1-2):209-15. PMC: 2259240. DOI: 10.1016/j.canlet.2007.11.002. View

12.

Liu Y, Li C, Chen P, Li X, Li M, Guo H . Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis. PLoS One. 2013; 8(6):e66716. PMC: 3691226. DOI: 10.1371/journal.pone.0066716. View

13.

Guo H, Guo J, Xie W, Yuan L, Sheng X . The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention. J Ovarian Res. 2018; 11(1):71. PMC: 6114234. DOI: 10.1186/s13048-018-0443-7. View

14.

Dou R, Ng K, Giovannucci E, Manson J, Qian Z, Ogino S . Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr. 2016; 115(9):1643-60. PMC: 4890569. DOI: 10.1017/S0007114516000696. View

15.

Feldman D, Krishnan A, Swami S, Giovannucci E, Feldman B . The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014; 14(5):342-57. DOI: 10.1038/nrc3691. View

16.

Amadori D, Serra P, Masalu N, Pangan A, Scarpi E, Bugingo A . Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway. Oncotarget. 2017; 8(8):13142-13156. PMC: 5355083. DOI: 10.18632/oncotarget.14482. View

17.

Li K, Luo Y, Mo Y, Shen J, Liu X, Li H . Association between vitamin D receptor gene polymorphisms and idiopathic hypocitraturia in a Chinese Bai population. Urolithiasis. 2018; 47(3):235-242. DOI: 10.1007/s00240-018-1069-3. View

18.

Dos Reis G, Gontijo N, Rodrigues K, Alves M, Ferreira C, Gomes K . Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review. J Obstet Gynaecol Res. 2017; 43(3):436-446. DOI: 10.1111/jog.13250. View

19.

Flugge J, Krusekopf S, Goldammer M, Osswald E, Terhalle W, Malzahn U . Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol. 2007; 63(11):997-1005. DOI: 10.1007/s00228-007-0367-4. View

20.

Chen L, Wei J, Zhang S, Lou Z, Wang X, Ren Y . Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis. Onco Targets Ther. 2018; 11:3267-3280. PMC: 5987782. DOI: 10.2147/OTT.S151002. View